首页>
外国专利>
Markers for pancreatic cancer recurrence prognosis prediction and its use
Markers for pancreatic cancer recurrence prognosis prediction and its use
展开▼
机译:胰腺癌复发预后的标志物及其应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed is a marker for predicting the prognosis of pancreatic cancer recurrence including proteins selected from the group consisting of alpha-2-antiplasmin, lumican, apolipoprotein CIII, alpha-2-macroglobulin, complement C4 gamma chain, lamin A/C, elongation factor Tu, triosephosphate isomerase, and carbonic anhydrase V. By the present invention, the proteins known to be specifically overexpressed or downregulated in the serum of patients with recurrent pancreatic cancer after surgical treatment can be useful as a biomarker for predicting the prognosis of pancreatic cancer recurrence before concurrent chemoradiotherapy.
展开▼